Skip to main content

UNIVERSAL TECHNICAL INSTITUTE INC

corporate_fare Company Profile

UNIVERSAL TECHNICAL INSTITUTE INC

UTI·NYSE·Trade & Services·CIK 0001261654

Universal Technical Institute, Inc. provides high-quality training programs and support services for in-demand careers through two main divisions: Universal Technical Institute (UTI) and Concorde Career Colleges. UTI operates 15 campuses across nine states, offering degree and non-degree technical training in transportation, skilled trades, and energy. UTI also provides manufacturer-specific advanced training, including student-paid electives and manufacturer or dealer-sponsored training, along with dealer technician training or instructor staffing services to manufacturers. Concorde Career Colleges, acquired on December 1, 2022, operates 17 campuses in eight states and online. Concorde offers degree, non-degree, certificate, and continuing education programs in allied health, dental, nursing, patient care, and diagnostic fields. Campuses offering degree-granting programs are designated as "Concorde Career College" where permitted by state regulations, while others are "Concorde Career Institute." Both divisions emphasize hands-on learning through labs, clinical placements, and externships, alongside classroom and blended delivery models. All campuses are institutionally accredited and eligible for federal student financial assistance, including Title IV Programs administered by the U.S. Department of Education, and other federal sources like the U.S. Department of Veterans Affairs and the Workforce Innovation and Opportunity Act.

UNIVERSAL TECHNICAL INSTITUTE INC (NYSE:UTI) is a publicly traded company in the Trade & Services sector. Wiseek monitors UTI SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Director-Affiliated Entity Sells $124.2M in UTI Stock
  • Coliseum Capital Sells $124M in UTI Stock, Exits >5% Stake
  • Director-Affiliated Entity Files Intent to Sell $173M in UTI Stock
  • Q2 Earnings Show Revenue & Student Growth Amidst Profitability Dip Due to Strategic Investments
  • UTI Q2 Revenue Up 6.7%, Misses Estimates; Profit Falls Sharply on Growth Investments

Financial Snapshot

Fiscal year ended September 30, 2025
Revenue
$835.62M
Net Income
$63.02M
Diluted EPS
$1.13
Op. Cash Flow
$97.33M
Free Cash Flow
$55.35M
Operating Income
$83.47M
Cash & Equivalents
$127.36M
Total Debt
$87.1M
Debt / Equity
0.27×
Net Margin
7.5%
Shares Outstanding
54.43M sh
Source: 10-K · filed 2025-11-26 · accession 0001261654-25-000025
Browse all tickers starting with U →
$39.14
52-week range · as of 2026-06-10 $21.29 – $45.74
Market cap
$2.16B
Volume
891.3K (0.6× avg)
3-mo avg 1.5M
Live data · 2026-06-14 02:00 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed UTI - Latest Insights

UTI
Jun 10, 2026, 5:59 PM EDT
Filing Type: 4
Importance Score:
9
Price at Filing: $39.55
Real-time Price: $39.14 info
Change: -$0.410 (-1%) info
Market Cap: $2.155B info
UTI
Jun 10, 2026, 5:52 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $39.55
Real-time Price: $39.14 info
Change: -$0.410 (-1%) info
Market Cap: $2.155B info
UTI
Jun 08, 2026, 6:42 PM EDT
Filing Type: 144
Importance Score:
9
Price at Filing: $41.00
Real-time Price: $39.14 info
Change: -$1.86 (-5%) info
Market Cap: $2.155B info
UTI
May 07, 2026, 8:59 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $35.65
Real-time Price: $39.14 info
Change: +$3.49 (+10%) info
Market Cap: $2.155B info
UTI
May 06, 2026, 4:26 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $35.27
Real-time Price: $39.14 info
Change: +$3.87 (+11%) info
Market Cap: $2.155B info
UTI
May 06, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $35.50
Real-time Price: $39.14 info
Change: +$3.64 (+10%) info
Market Cap: $2.155B info
UTI
Mar 06, 2026, 6:00 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $34.99
Real-time Price: $39.14 info
Change: +$4.15 (+12%) info
Market Cap: $2.155B info
UTI
Mar 04, 2026, 8:16 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $35.82
Real-time Price: $39.14 info
Change: +$3.32 (+9%) info
Market Cap: $2.155B info
UTI
Mar 02, 2026, 7:45 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $37.40
Real-time Price: $39.14 info
Change: +$1.74 (+5%) info
Market Cap: $2.155B info
UTI
Feb 04, 2026, 4:04 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $27.86
Real-time Price: $39.14 info
Change: +$11.28 (+40%) info
Market Cap: $2.155B info
UTI
Jan 20, 2026, 4:33 PM EST
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $27.19
Real-time Price: $39.14 info
Change: +$11.95 (+44%) info
Market Cap: $2.155B info